Drug
Sevirumab
Sevirumab: highest development phase Phase 1, developed by Sandoz. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sevirumab NCT00002268 | Phase 1 | Cytomegalovirus Infections |
Latest
No recent events.
Follow Sevirumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.